We are live on ! Find out more
GRNAW

GreenLight Biosciences Holdings, PBC Warrant

Delisted

GRNAW was delisted on the 21st of July, 2023.

19 hedge funds and large institutions have $7.77M invested in GreenLight Biosciences Holdings, PBC Warrant in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

14% more capital invested

Capital invested by funds: $6.83M → $7.77M (+$936K)

10% less funds holding

Funds holding: 2119 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
2
Closed
2
Calls
$787K
Puts
Net Calls
+$787K
Net Calls Change
+$36K

GRNAW Hedge Fund Activity: Q3 2022 in Review

19 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Warrant (GRNAW) for Q3 2022, worth a combined $7.77M — up 14% from $6.83M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of GRNAW and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was LMR Partners, adding an estimated $96.9K. The largest seller was Aristeia Capital, exiting entirely with an estimated $11K sold.

  • 19 institutional investors held GreenLight Biosciences Holdings, PBC Warrant (GRNAW) as of Q3 2022, down from 21 in Q2 2022.
  • Funds reported $7.77M of GreenLight Biosciences Holdings, PBC Warrant stock for Q3 2022, up 14% quarter-over-quarter.
  • 0 funds opened new GreenLight Biosciences Holdings, PBC Warrant positions in Q3 2022 and 2 closed out, a net change of -2 holders.
  • The largest GreenLight Biosciences Holdings, PBC Warrant buyer in Q3 2022 was LMR Partners, an estimated $96.9K added.
  • The largest GreenLight Biosciences Holdings, PBC Warrant seller in Q3 2022 was Aristeia Capital, an estimated $11K sold.

Based on aggregated 13F filings for Q3 2022.